ClinicalTrials.gg
RecruitingNCT06523127Updated Jul 26, 2024

Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues

An observational study in Quality of Life, Brain Injuries and Post ICU, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
14
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 72 studies in Brain Injuries with a site in France — 18 open to participants now, 19 under way, none of them phase 3. Brain Injuries · France.

Planned enrollment
34th of 36
14 · median 124
Started
2024
with 3 others
Observational
36 of 72
12 open now
Primary completion
2024-09
later than 1 of 18 live
Registered
59th of 72
by date

Among the 72 studies in Brain Injuries with a site in France, this one is the 34th largest by planned enrollment of the 36 observational ones that give a count, is one of 4 that started in 2024, is one of 36 observational ones, reaches primary completion later than 1 of the 18 other live ones, and was the 59th registered.

Brain Injuries

947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.

Browse Brain Injuries studies →

Open to participants now

18 of the 72 studies in Brain Injuries with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Brain Injuries with a site in France, or all of them as a file.
02

Study summary

Withdrawal of life-sustaining treatment affects 10-15% of ICU patients, including those with severe acute brain injury, whose care appears futile in terms of prognosis based on clinical and paraclinical data, expected quality of life, patient preferences, age, or reduced quality of life.

There are few studies on withholding treatment compared with withdrawing treatment, and even fewer on survivors after a decision to withhold treatment.

Quality of life is defined by WHO as "an individual's perception of his or her position in life in the context of the culture and value systems in which he or she lives and in relation to his or her goals, expectations, standards and concerns". The relationship between quality of life and neurological outcome after severe acute brain injury is controversial and therefore difficult to predict.

That's why the investigators question the legitimacy of making decisions to withhold treatment from patients with severe acute brain injury based on their expected quality of life, when this prediction is uncertain.

03

Conditions studied

  • Quality of Life
  • Brain Injuries
  • Post ICU

Browse trials for

Keywords

  • Quality of life
  • Withholding of life-sustaining treatments
  • Withdrawal of life-sustaining treatment
  • Severe acute brain injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with acute brain injury admitted to intensive care in 2022 will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients:

  • with severe acute brain injury (TBI, stroke, central nervous system infection).
  • admitted in the neurocritical care unit in 2022.
  • followed up 24 months after ICU between 15th April 2024 and 31st August 2024.

Exclusion criteria

Exclusion Criteria:

Patients:

  • death in 2024,
  • refusal by patient or relative.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
14 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with severe acute brain injury and with withholding of life-sustaining treatment

    Assessment of quality of life in patients with severe acute brain injury based on the audio recording during post-ICU follow-up.

    Other: Recording data from the ICU stay and the post-ICU follow-up.

  • Patients with severe acute brain injury and without withholding of life-sustaining treatment

    Assessment of quality of life in patients with severe acute brain injury based on the audio recording during post-ICU follow-up.

    Other: Recording data from the ICU stay and the post-ICU follow-up.

Interventions

  • OtherRecording data from the ICU stay and the post-ICU follow-up.

    Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis

06

What researchers measure

Primary outcomes

  1. Interpretative Phenomenological Analysis

    Qualitative analysis of the quality of life in patients with severe acute brain injury and with withholding of life-sustaining treatment

    Time frame: 24 months after ICU discharge

Secondary outcomes

  1. International survey among neurointensivists from ANARLF network - questionnaires

    Comparison of the number of decisions of withholding treatment in the clinical cases versus real life

    Time frame: Month : 3

  2. International survey among neurointensivists from ANARLF network - follow-up

    Comparison of the predicted neurological outcome and quality of life by neurointensivists versus the real neurological outcome and quality of life assessed at the post-ICU follow-up.

    Time frame: Month : 3

07

Study locations

1 of 1 sites recruiting
  • Centre Hospitalier Universitaire de Saint Etienne
    Saint Etienne, 42055, France
    Recruiting
    • Marie DAKENG, resident · Contactmcgperret@gmail.com · (0)4 77 82 83 29
    • Marie DAKENG, resident · Principal investigator
    • Nory ELHADJENE, MD · Sub investigator
    • Jérôme MOREL, MD PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Sep 2024, 3 months after the start.

Of 144 non-industry observational studies under Brain Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 73. This study's planned 3 months is below that.

Counting every sponsor, half of 149 studies reached it within 31 months; a quarter within 16 and three quarters within 73.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2024
First posted
Jul 26, 2024
StartActual
Jun 3, 2024
Primary completionEst.
Sep 2024
CompletionEst.
Sep 2024
Last update
Jul 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06523127
Responsible party
Sponsor
First posted
Jul 26, 2024
Start date
Jun 3, 2024
Primary completion
Sep 2024 (estimated)
Completion
Sep 2024 (estimated)
Last update
Jul 26, 2024

Study contacts

Marie DAKENG, resident
Contact
mcgperret@gmail.com
(0)4 77 82 83 29 ext. +33
Nory ELHADJENE, MD
Contact
Nory.ELHADJENE@chu-st-etienne.fr
(0)4 77 82 83 29 ext. +33
Marie DAKENG, resident
principal investigator · CHU SAINT ETIENNE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion